APA
Löwenberg B., Suciu S., Archimbaud E., Haak H., Stryckmans P., de Cataldo R., Dekker A. W., Berneman Z. N., Thyss A., van der Lelie J., Sonneveld P., Visani G., Fillet G., Hayat M., Hagemeijer A., Solbu G. & Zittoun R. (19980324). Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Chicago
Löwenberg B, Suciu S, Archimbaud E, Haak H, Stryckmans P, de Cataldo R, Dekker A W, Berneman Z N, Thyss A, van der Lelie J, Sonneveld P, Visani G, Fillet G, Hayat M, Hagemeijer A, Solbu G and Zittoun R. 19980324. Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Harvard
Löwenberg B., Suciu S., Archimbaud E., Haak H., Stryckmans P., de Cataldo R., Dekker A. W., Berneman Z. N., Thyss A., van der Lelie J., Sonneveld P., Visani G., Fillet G., Hayat M., Hagemeijer A., Solbu G. and Zittoun R. (19980324). Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
MLA
Löwenberg B, Suciu S, Archimbaud E, Haak H, Stryckmans P, de Cataldo R, Dekker A W, Berneman Z N, Thyss A, van der Lelie J, Sonneveld P, Visani G, Fillet G, Hayat M, Hagemeijer A, Solbu G and Zittoun R. Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 19980324.